combine@alvar.ug

Maternal Influences on Access to and Use of Infant ARVs and HIV Health Services in Uganda

Maternal Influences on Access to and Use of Infant ARVs and HIV Health Services in Uganda

Show simple record

dc.contributor.author Bergmann, Julie N.
dc.contributor.author Wanyenze, Rhoda K.
dc.contributor.author Makumbi, Fred
dc.contributor.author Naigino, Rose
dc.contributor.author Kiene, Susan M.
dc.contributor.author Stockman, Jamila K.
dc.date.accessioned 2021-01-01T21:58:00Z
dc.date.available 2021-01-01T21:58:00Z
dc.date.issued 2017
dc.identifier.issn 1090-7165
dc.identifier.uri http://combine.alvar.ug/handle/1/48116
dc.description.abstract Vertical transmission of HIV is responsible for about 14 % of new HIV cases reported each year in sub-Saharan Africa. Barriers that prevent women from accessing and using antiretroviral medications (ARVs) for themselves and their infants perpetuate the epidemic. To identify influences on access to and use of infant HIV health services, specifically nevirapine administration, we conducted a mixed methods study among HIV-positive women in Uganda. This included a cross-sectional survey (n = 384) and focus group discussions (n = 6, 5-9 participants each). Of the 384 women, 80 % gave nevirapine to their infants within 72 h of birth. Factors independently associated with nevirapine administration were lack of maternal adherence to ARVs (AOR 3.55, 95 % CI 1.36-9.26) and attending a support group (AOR 2.50, 95 % CI 1.06-5.83). Non-health facility births were inversely related to nevirapine use (AOR 0.02, 95 % CI 0.003-0.09). Focus group discussions identified four themes impacting access and use: attending a support group, health care worker attitudes, lack of partner support, and poor health messaging regarding ARVs. Improving health care worker messaging regarding ARVs and providing women with needed support to access and use infant ARV prophylaxis is critical to overcoming access barriers. Eliminating these barriers may prevent numerous HIV infections each year saving the lives of many HIV-exposed infants.
dc.description.sponsorship University of California, San DiegoUniversity of California System
dc.description.sponsorship Ugandan Ministry of Health Global Fund [UGD-708-G07-H]
dc.description.sponsorship National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [K01DA031593]
dc.description.sponsorship National Institute of Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [L60MD003701]
dc.description.sponsorship NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [K01DA031593, K01DA031593, K01DA031593, K01DA031593, K01DA031593] Funding Source: NIH RePORTER
dc.language English
dc.publisher SPRINGER/PLENUM PUBLISHERS
dc.relation.ispartof AIDS and Behavior
dc.subject Hiv-Exposed Infants
dc.subject Art Adherence
dc.subject Vertical Transmission Of Hiv
dc.subject Prevention Of Mother To Child Transmission
dc.subject Sub-Saharan Africa
dc.title Maternal Influences on Access to and Use of Infant ARVs and HIV Health Services in Uganda
dc.type Article
dc.identifier.isi 000408092300014
dc.identifier.doi 10.1007/s10461-016-1528-1
dc.identifier.pmid 2755
dc.publisher.city NEW YORK
dc.publisher.address 233 SPRING ST, NEW YORK, NY 10013 USA
dc.identifier.eissn 1573-3254
dc.identifier.volume 21
dc.identifier.issue 9
dc.identifier.spage 2693
dc.identifier.epage 2702
dc.subject.wc Public, Environmental & Occupational Health
dc.subject.wc Social Sciences, Biomedical
dc.subject.sc Public, Environmental & Occupational Health
dc.subject.sc Biomedical Social Sciences
dc.description.pages 10
dc.subject.kwp Active Antiretroviral Therapy
dc.subject.kwp To-Child Transmission
dc.subject.kwp Follow-Up
dc.subject.kwp Infected Children
dc.subject.kwp Randomized-Trial
dc.subject.kwp Prevention
dc.subject.kwp Care
dc.subject.kwp Intrapartum
dc.subject.kwp Challenges
dc.subject.kwp Zidovudine
dc.description.affiliation Univ Calif San Diego, Div Global Publ Hlth, Dept Med, 9500 Gilman Dr,MC 0507, La Jolla, CA 92093 USA
dc.description.affiliation San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA
dc.description.affiliation Makerere Univ, Sch Publ Hlth, Kampala, Uganda
dc.description.email jnbergmann@ucsd.edu
dc.description.corr Bergmann, JN (corresponding author), Univ Calif San Diego, Div Global Publ Hlth, Dept Med, 9500 Gilman Dr,MC 0507, La Jolla, CA 92093 USA.; Bergmann, JN (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.
dc.description.orcid Kiene, Susan/0000-0001-8922-5289


This record appears in the collections of the following institution(s)

Show simple record

Search Entire Database


Browse

My Account